| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstract
|
|
|
2012
|
|
5 |
p. 340-
1 p.
|
artikel
|
| 2 |
Acknowledgments
|
Becker, Gavin J.
|
|
2012
|
|
5 |
p. 404-
1 p.
|
artikel
|
| 3 |
A Japanese approach for CKD-MBD
|
Yokoyama, Keitaro
|
|
2013
|
|
5 |
p. 451-456
6 p.
|
artikel
|
| 4 |
A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease
|
Kuro-o, Makoto
|
|
2013
|
|
5 |
p. 420-426
7 p.
|
artikel
|
| 5 |
Biographic and disclosure information
|
|
|
2012
|
|
5 |
p. 398-403
6 p.
|
artikel
|
| 6 |
Calcimimetics and outcomes in CKD
|
Drüeke, Tilman B.
|
|
2013
|
|
5 |
p. 431-435
5 p.
|
artikel
|
| 7 |
Chapter 6: Blood pressure management in children with CKD ND
|
|
|
2012
|
|
5 |
p. 372-376
5 p.
|
artikel
|
| 8 |
Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus
|
|
|
2012
|
|
5 |
p. 363-369
7 p.
|
artikel
|
| 9 |
Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus
|
|
|
2012
|
|
5 |
p. 357-362
6 p.
|
artikel
|
| 10 |
Chapter 7: Blood pressure management in elderly persons with CKD ND
|
|
|
2012
|
|
5 |
p. 377-381
5 p.
|
artikel
|
| 11 |
Chapter 5: Blood pressure management in kidney transplant recipients (CKD T)
|
|
|
2012
|
|
5 |
p. 370-371
2 p.
|
artikel
|
| 12 |
Chapter 8: Future directions and controversies
|
|
|
2012
|
|
5 |
p. 382-387
6 p.
|
artikel
|
| 13 |
Chapter 1: Introduction
|
|
|
2012
|
|
5 |
p. 343-346
4 p.
|
artikel
|
| 14 |
Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients
|
|
|
2012
|
|
5 |
p. 347-356
10 p.
|
artikel
|
| 15 |
Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
|
Hamano, Takayuki
|
|
2013
|
|
5 |
p. 469-475
7 p.
|
artikel
|
| 16 |
Foreword
|
Kasiske, Bertram L.
|
|
2012
|
|
5 |
p. 338-
1 p.
|
artikel
|
| 17 |
Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients
|
Streja, Elani
|
|
2013
|
|
5 |
p. 462-468
7 p.
|
artikel
|
| 18 |
Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
|
Fukuma, Shingo
|
|
2013
|
|
5 |
p. 436-441
6 p.
|
artikel
|
| 19 |
Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
|
Fukagawa, Masafumi
|
|
2013
|
|
5 |
p. 419-
1 p.
|
artikel
|
| 20 |
Mechanisms of arterial calcifications and consequences for cardiovascular function
|
London, Gérard M.
|
|
2013
|
|
5 |
p. 442-445
4 p.
|
artikel
|
| 21 |
Methods for guideline development
|
|
|
2012
|
|
5 |
p. 388-397
10 p.
|
artikel
|
| 22 |
Notice
|
|
|
2012
|
|
5 |
p. 337-
1 p.
|
artikel
|
| 23 |
Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
|
Goto, Shunsuke
|
|
2013
|
|
5 |
p. 457-461
5 p.
|
artikel
|
| 24 |
References
|
|
|
2012
|
|
5 |
p. 405-414
10 p.
|
artikel
|
| 25 |
Summary of Recommendation Statements
|
|
|
2012
|
|
5 |
p. 341-342
2 p.
|
artikel
|
| 26 |
Uremic osteoporosis
|
Kazama, Junichiro J.
|
|
2013
|
|
5 |
p. 446-450
5 p.
|
artikel
|
| 27 |
Vitamin D receptor activation: cardiovascular and renal implications
|
Nigwekar, Sagar U.
|
|
2013
|
|
5 |
p. 427-430
4 p.
|
artikel
|
| 28 |
Work Group Membership
|
|
|
2012
|
|
5 |
p. 339-
1 p.
|
artikel
|
Tijdschrift beschrijving